Ryan Specialty Holdings, Inc. (NYSE:RYAN) Receives $73.50 Consensus PT from Brokerages

Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) have been assigned an average recommendation of “Hold” from the twelve brokerages that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $73.50.

A number of research analysts have issued reports on the stock. The Goldman Sachs Group upped their target price on shares of Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research report on Wednesday, October 9th. Wells Fargo & Company increased their price objective on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a report on Thursday, October 10th. Bank of America lifted their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a report on Thursday, October 10th. Barclays increased their price target on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Finally, BMO Capital Markets upgraded Ryan Specialty from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $65.00 to $75.00 in a research report on Tuesday, September 24th.

Ryan Specialty Price Performance

Ryan Specialty stock opened at $64.40 on Tuesday. The business has a 50 day simple moving average of $69.67 and a 200 day simple moving average of $64.99. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company has a market capitalization of $16.86 billion, a PE ratio of 83.64, a price-to-earnings-growth ratio of 1.52 and a beta of 0.67. Ryan Specialty has a one year low of $41.65 and a one year high of $75.97.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting the consensus estimate of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. During the same period in the previous year, the business earned $0.32 EPS. Ryan Specialty’s revenue was up 20.5% compared to the same quarter last year. On average, sell-side analysts forecast that Ryan Specialty will post 1.82 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were paid a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.68%. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.

Insider Transactions at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction on Wednesday, December 18th. The stock was sold at an average price of $65.17, for a total transaction of $2,280,950.00. Following the sale, the director now owns 50,400 shares in the company, valued at $3,284,568. The trade was a 40.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Mark Stephen Katz sold 14,790 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the sale, the executive vice president now owns 12,386 shares in the company, valued at approximately $884,236.54. This trade represents a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 126,936 shares of company stock valued at $8,536,282. 11.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Ryan Specialty

Institutional investors have recently made changes to their positions in the stock. State Street Corp boosted its stake in Ryan Specialty by 1.5% during the third quarter. State Street Corp now owns 3,273,093 shares of the company’s stock worth $217,301,000 after acquiring an additional 49,198 shares in the last quarter. Janus Henderson Group PLC increased its holdings in shares of Ryan Specialty by 0.4% during the third quarter. Janus Henderson Group PLC now owns 3,148,916 shares of the company’s stock valued at $209,058,000 after acquiring an additional 13,986 shares in the last quarter. Blair William & Co. IL raised its position in shares of Ryan Specialty by 3.4% during the second quarter. Blair William & Co. IL now owns 2,866,003 shares of the company’s stock worth $165,970,000 after purchasing an additional 94,663 shares during the period. Barclays PLC raised its holdings in Ryan Specialty by 1.1% during the third quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock worth $108,994,000 after buying an additional 17,267 shares during the last quarter. Finally, Eagle Asset Management Inc. lifted its stake in shares of Ryan Specialty by 32.1% in the third quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock valued at $98,555,000 after buying an additional 335,180 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.